CCSD code 0008B (NK Assay Full Panel): UK billing guide

Key Takeaways

CCSD code 0008B is the NK Assay Full Panel, a Chapter 34 (Pathology) diagnostic blood test in the UK CCSD schedule — a laboratory service charge, not a surgical procedure code

0008B (NK Assay Full Panel) and 0007B (NK Cell Inhibition Panel) are sibling codes. Bill the one that matches the assay the laboratory actually performed

NK cell panels are ordered mostly in reproductive immunology, for recurrent miscarriage or repeated implantation failure, where insurer coverage is often restricted — confirm cover and pre-authorisation before the test

Pabau’s claims management software supports CCSD diagnostic code workflows for UK private healthcare providers

CCSD code 0008B is the NK Assay Full Panel, a diagnostic blood test listed in Chapter 34 (Pathology) of the CCSD (Clinical Coding and Schedule Development Group) Diagnostic Tests Schedule. It measures natural killer (NK) cell activity and is ordered most often in reproductive immunology, for patients investigated for recurrent miscarriage or repeated implantation failure.

This guide covers what the code represents, how it differs from the sibling NK Cell Inhibition Panel (0007B), which insurers recognise it, and the documentation you need to get paid first time.

CCSD code 0008B: Definition and chapter classification

CCSD code 0008B is the NK Assay Full Panel, a diagnostic test code rather than a procedure code. The CCSD FAQs confirm that diagnostic test codes represent laboratory service charges rather than surgical or clinical procedures, so they load differently in practice management systems and follow distinct pre-authorisation pathways compared with procedural codes.

The code sits in Chapter 34 (Pathology) of the CCSD Diagnostic Tests Schedule. Chapter 34 covers specialised laboratory investigations, including immunological panels, cellular assays, and related blood science tests.

The NK Assay Full Panel is the broader of the two natural killer cell codes in that chapter, alongside its sibling the NK Cell Inhibition Panel (0007B). Our CCSD code guides cover the full set of Chapter 34 codes.

A full NK panel reports natural killer cell numbers and activity, giving a more complete immunological picture than the inhibition-focused 0007B panel. The CCSD Schedule is the authority for the exact narrative and any coding notes.

Because it is login-gated at the official CCSD portal, confirm the current description against the CCSD Diagnostic Tests Schedule before each claim cycle, as codes are periodically added, amended, and retired.

CCSD code 0008B vs 0007B: Choosing the right NK cell panel

The key coding decision when billing NK cell testing is the choice between 0007B and 0008B. Both codes sit in Chapter 34 Pathology and both describe natural killer cell assays, but they are distinct panels: 0008B is the full NK panel, while 0007B is the narrower inhibition panel.

The selection rule is straightforward: the code must match the assay the laboratory actually ran. If the lab report names the NK Cell Inhibition Panel, use 0007B. If it names the full NK panel, use 0008B.

Insurers check the billed code against the laboratory report during adjudication, so a mismatch between the code and the lab’s assay description is a common cause of rejection for this code pair.

Never select 0008B based on the referring clinician’s request alone. The final selection must align with the test the laboratory performed and reported. When in doubt, contact the lab directly and ask which CCSD code it recommends for the assay it ran.

Which insurers accept CCSD code 0008B

All major UK private medical insurers (PMIs) use the CCSD schedule as their standard coding framework. CCSD code 0008B, like other CCSD-coded diagnostics, is generally recognised across these insurers, including Bupa, AXA Health, Aviva, and Vitality Health. Always confirm code-level recognition and coverage with the specific insurer.

Recognition does not automatically mean coverage. Cover for NK cell and reproductive-immunology testing is often restricted, because its clinical value in fertility care is debated, so many insurers treat it as a non-routine or excluded benefit.

Use the Bupa code search portal to confirm whether 0008B is a covered benefit for a specific membership. For Vitality, the Vitality fee finder allows code-level fee lookups. The Allianz Care fee schedule lists CCSD-coded fees for covered diagnostics.

Check the Bupa CCSD code guide for an overview of how Bupa processes CCSD diagnostic claims, including the distinction between covered and non-covered diagnostic panels. For any specialised immunological panel, these insurer-specific lookups are a necessary step before every claim submission.

Insurer-specific considerations

• Bupa: Confirms coverage through the Bupa code search portal. Non-covered diagnostics are listed explicitly. Pre-authorisation may be required for specialised panels.
• AXA Health: Uses CCSD codes for all specialist and diagnostic billing. Refer to the AXA Health specialist procedure code lookup for covered status.
• Aviva: Coverage of Chapter 34 pathology codes depends on the specific policy purchased. Verify via Aviva’s provider portal before submitting.
• Vitality Health: The Vitality fee finder provides code-level lookup. Vitality policies vary significantly in diagnostic coverage. Confirm at the policy level, not just the code level.
• Allianz Care: CCSD codes are listed in the published UK fee schedule. The schedule specifies which codes attract a fee and at what rate.

Pre-authorisation requirements for CCSD code 0008B

Pre-authorisation requirements for CCSD code 0008B vary by insurer and, within each insurer, by policy type. No universal rule applies. The safest workflow is to assume pre-authorisation is required and verify with the relevant PMI before the test is performed.

Because the NK Assay Full Panel is a specialised reproductive-immunology test, most major insurers require prior approval and clear clinical justification. Document the indication before requesting authorisation. The insurer will typically ask for:

• What condition the panel is investigating
• What the referring clinician’s reasoning is
• Whether alternative lower-cost tests have been considered

Refer to the CCSD code 0048B guidance for a worked example of how pre-authorisation workflows differ across UK insurers. The same principles apply to 0008B.

What to include in a pre-authorisation request

• Patient’s policy number and membership details
• The CCSD code being requested (0008B) and its description (NK Assay Full Panel)
• The referring clinician’s name, GMC number, and stated clinical indication
• The name of the laboratory performing the test
• Whether related tests are being ordered at the same time

Documentation requirements when billing CCSD code 0008B

A claim for CCSD code 0008B needs a referral letter, a laboratory report naming the specific assay, and a pre-authorisation reference where applicable. The checklist below covers each in detail.

The laboratory report is the critical document. Insurers compare the assay named in the report against the billed code during adjudication. If the report names a test that does not map to 0008B, the claim fails regardless of the clinical rationale. Attach or reference the report number on the claim submission whenever the insurer’s portal allows it.

Practice management software like Pabau keeps referral correspondence, lab reports, and pre-authorisation references together in one patient record through digital clinical documentation forms. This matters at audit: if an insurer queries a claim six months later, the documentation trail needs to be retrievable in seconds.

The same documentation approach applies across other CCSD codes, including 0011G, 0636G, and 0607U.

Minimum documentation checklist

• Referral letter or clinical correspondence stating the investigation reason
• Laboratory report naming the specific NK cell assay performed
• Pre-authorisation reference number (where applicable)
• Consulting clinician’s name and GMC number on the claim
• Patient’s insurer policy number and date of service

This checklist mirrors what most insurers expect for other CCSD diagnostic claims, including 0660U.

Manage CCSD claims without the spreadsheet chaos

Pabau keeps your CCSD diagnostic codes, pre-authorisation references, lab reports, and insurer submissions in one place. Book a demo to see how UK private healthcare providers use Pabau to reduce claim rejections.

Book a demo

Common billing errors and claim denials for CCSD code 0008B

Four errors account for the majority of rejections on CCSD code 0008B claims. Understanding them before submission is more efficient than resolving them after.

A fifth issue applies to practices billing multiple diagnostic codes on a single claim: combination restrictions. The CCSD Schedule lists any unacceptable code combinations for a given code, so check the entry for 0008B before billing it alongside another NK cell or immunological code. Confirming this in the current schedule avoids a rejection that clinical rationale alone will not overturn.

For practices managing several diagnostic claims at once, a structured claim workflow reduces the risk of these errors reaching adjudication. Reference the Bupa fee schedule for the current recognised fee alongside Bupa’s own combination rules.

How to submit a CCSD code 0008B claim electronically

UK private healthcare claims are submitted electronically through Healthcode, the UK’s dedicated electronic claims clearinghouse for private medical billing. Healthcode validates the claim format before it reaches the insurer, so a structurally incorrect submission is rejected at the gateway rather than after adjudication.

For CCSD code 0008B, the submission fields that require care are the code type field (diagnostic, not procedure), the date of service (the date the laboratory performed the test, not the date of the referral), and the insurer reference field (which must contain the pre-authorisation number where one was obtained).

The same submission fields apply when billing other CCSD codes, such as 0047G and 0054S.

Maintaining accurate patient records and a data protection checklist ensures that the documentation supporting each claim is retained securely and retrievably. Insurer audits can request supporting documentation years after a claim is settled, so good record-keeping at the point of billing prevents problems later.

Electronic submission checklist for 0008B

• Code type: diagnostic (not procedural)
• CCSD code: 0008B, NK Assay Full Panel (verify against the current CCSD Diagnostic Tests Schedule)
• Date of service: the date the laboratory performed the assay
• Insurer reference: pre-authorisation number (where applicable)
• Clinician details: referring and/or consulting clinician’s GMC number
• Patient details: insurer policy number and date of birth

Related CCSD codes in Chapter 34 Pathology

CCSD code 0008B sits within a cluster of Chapter 34 immunological and haematological panel codes. Knowing the adjacent codes helps prevent miscoding and supports billing decisions.

• 0007B: NK Cell Inhibition Panel. The closest sibling to 0008B. Billed when the laboratory performs the inhibition-specific assay rather than the full NK panel.
• Other CCSD codes: The schedule includes many other diagnostic and procedure codes, such as 0514G and 0455O. Refer to the current CCSD Diagnostic Tests Schedule via the official CCSD portal for the full list of codes adjacent to 0008B.

For practices building a reference library of commonly billed CCSD codes, private practice management software with CCSD code support reduces the risk of using outdated or superseded codes.

The CCSD schedule is updated periodically, so always verify against the current schedule before billing, including for related codes such as 0043G and 0048F.

Conclusion

CCSD code 0008B is the NK Assay Full Panel, a specialised Chapter 34 Pathology diagnostic test code where accurate billing depends on three decisions made before the claim is submitted: selecting 0008B rather than 0007B based on the assay the laboratory actually performed, securing pre-authorisation from the relevant insurer, and documenting the laboratory report clearly.

Pabau’s private healthcare claims management module keeps CCSD diagnostic code records, pre-authorisation references, and lab documentation in one place for UK private healthcare providers. To see how it handles CCSD diagnostic billing workflows, book a demo.

Continue your research

Need to understand how UK private insurers process CCSD diagnostic claims? Bupa CCSD codes guide covers how Bupa handles CCSD procedure and diagnostic code submissions, including covered benefits and pre-authorisation.

Billing the sibling Chapter 34 code alongside 0008B? The NK Cell Inhibition Panel (0007B) is the closest comparison. Our CCSD code guides cover the clinical and billing distinction between the two NK cell panel codes in detail.

Looking for a full private practice billing workflow for UK clinics? Claims management software shows how Pabau supports CCSD code workflows, insurer submissions, and claim tracking for UK private healthcare providers.

Frequently asked questions